VistaGen Therapeutics, Inc.
VTGN · NASDAQ
9/30/2025 | 6/30/2025 | 3/31/2025 | 12/31/2024 | |
|---|---|---|---|---|
| Operating Activities | – | – | – | – |
| Net Income | -$19,417 | -$15,095 | -$13,635 | -$14,089 |
| Dep. & Amort. | $185 | $169 | $166 | $161 |
| Deferred Tax | $0 | $0 | $0 | $0 |
| Stock-Based Comp. | $1,096 | $916 | $963 | $1,080 |
| Change in WC | $4,523 | -$4,714 | $2,572 | $2,670 |
| Other Non-Cash | -$146 | -$122 | -$128 | -$102 |
| Operating Cash Flow | -$13,759 | -$18,846 | -$10,062 | -$10,280 |
| Investing Activities | – | – | – | – |
| PP&E Inv. | -$60 | -$65 | -$88 | $0 |
| Net Acquisitions | $0 | $0 | $0 | $0 |
| Inv. Purchases | -$2,034 | -$8,723 | -$3,915 | -$2,421 |
| Inv. Sales/Matur. | $2,000 | $8,000 | $4,530 | $1,999 |
| Other Inv. Act. | $0 | $0 | $0 | $0 |
| Investing Cash Flow | -$94 | -$788 | $527 | -$422 |
| Financing Activities | – | – | – | – |
| Debt Repay. | -$274 | $930 | $0 | $0 |
| Stock Issued | $27,928 | $558 | $1,951 | $1,058 |
| Stock Repurch. | $0 | $0 | $0 | $0 |
| Dividends Paid | $0 | $0 | $0 | $0 |
| Other Fin. Act. | $0 | $0 | $0 | $113 |
| Financing Cash Flow | $27,654 | $1,488 | $1,951 | $1,171 |
| Forex Effect | $0 | $0 | $0 | $0 |
| Net Chg. in Cash | $13,801 | -$18,146 | -$7,584 | -$9,531 |
| Supplemental Information | – | – | – | – |
| Beg. Cash | $48,985 | $67,131 | $74,715 | $84,246 |
| End Cash | $62,786 | $48,985 | $67,131 | $74,715 |
| Free Cash Flow | -$13,819 | -$18,846 | -$10,150 | -$10,280 |